Table 4.
Study concepts identified within OMOPa and any mapping to ICD-10b, dm+dc, SNOMED CTd, or Read v2 in Wales.
| Primary term | OMOP ATHENAe concept ID | ICD-10 | dm+d | SNOMED CT | Read v2 |
| CVSTf (nonstandard to standard map) | 10083037 | I63.6, I67.6, U07.7 (vaccine caused adverse effects) and P3.344 (CVST in hospitalized adults) | N/Ag | N/A | N/A |
| CVST (standard to nonstandard map) | 10083037 | I63.6, 167.6, UO7.7 (vaccine caused adverse effects) | N/A | N/A | N/A |
| Anaphylaxis (localized) | 4034658 | T78.2 (anaphylactic shock unspecified) | N/A | N/A | N/A |
| Anaphylaxis | 441202 | 45537000 (anaphylactic shock unspecified) | N/A | N/A | SN50.11 |
| Anaphylaxis (anaphylactic shock due to adverse effect of correct medicinal substance properly administered) | 45376003 | 45537000 (anaphylactic shock unspecified), 19746 | N/A | N/A | SN50110 |
| Anaphylaxis (drug induced) | 241937000 | 45537000 (anaphylactic shock unspecified) | N/A | N/A | SN50.00, 14M5.00 |
| Anaphylaxis (procedure) | 42537947 | 45537000 (anaphylactic shock unspecified) | N/A | N/A | SN50.11, SN50.00, 14M5.00 |
| Anaphylaxis (due to substance) | 4221182 | 45537000 (anaphylactic shock unspecified) | N/A | N/A | SN50.11, SN50.00, 14M5.00 |
aOMOP: Observational Medical Outcomes Partnership.
bICD-10: International Classification of Disease Tenth Revision.
cdm+d: Dictionary of Medicines and Devices.
dSNOMED CT: Systematized Nomenclature of Medicine Clinical Trials.
eATHENA: Automated Terminology Harmonization, Extraction, and Normalization for Analytics.
fCVST: cerebral venous sinus thrombosis.
gN/A: not applicable.